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Summary The effect of a combination of lithotripter shock waves and cytotoxic drugs was examined in vitro.
L1210 cells in suspension were exposed to shock waves during incubation with cisplatin, doxurubicin,
daunorubicin, THP-doxorubicin, or aclacinomycin. Proliferation was determined using the 3-4,5 dimethyl-
thiazol-2,5 diphenyl tetrazolium bromide assay. Dose enhancement ratios were calculated for each drug in
order to determine the effect of the additional exposure to shock waves. In addition, partition coefficients and
ICms of the drugs were determined. It was found, that the dose enhancement ratios increased for the drugs
with decreasing cytotoxicity. The effect of all five drugs was enhanced by shock waves to a higher degree at
7 min incubation as compared to 50 min incubation. The effect of cisplatin was most significantly enhanced,
with a dose enhancement ratio of 6.7 at 7 min incubation. The enhancement increased with the operating
voltage used for generating the shock waves, and was only present when cells were exposed to shock waves
during the incubation with the drug. An increase in cellular membrane permeability is proposed as the
mechanism of interaction between shock waves and drugs.
Lithotripter shock waves are pressure pulses of high amp-
litude and short duration which are used in medicine for the
disintegration of urinary and biliary calculi (Chaussy et al.,
1980; Sauerbruch et al., 1986). In liver and kidney they can
cause haemorrhages, vessel wall damage and venous thrombi
(Delius et al., 1988; Jaeger et al., 1988; Ponchon et al., 1989).
The increasing knowledge of the side effects of shock waves
in tissues led to investigations of their effect on tumour
tissue. Several authors found reduction of tumour volume or
even complete remission in small experimental tumours
(Russo et al., 1986; Oosterhof et al., 1990; Weiss et al., 1990).
In some experiments, the effect could be enhanced when
cytotoxic drugs were given in combination with shock waves
(Randazzo et al., 1988; Holmes et al., 1990; Lee et al., 1990;
Oosterhof et al., 1990; Weiss et al., manuscript in prepara-
tion). An enhanced effect of a combined application of shock
waves and cytotoxic drugs was also demonstrated in tumour
cell cultures (Oosterhof et al., 1989; Wilmer et al., 1989; Lee
et al., 1990). Recently, it was reported that ultrasound can
enhance the cytotoxicity of doxorubicin (Loverock et al.,
1990).
Only a limited number of cytotoxic drugs has so far been
tested in combination with shock waves. In this study the
combined effect of shock waves and five cytotoxic drugs,
cisplatin, and the anthracylcine antibiotics doxorubicin, dau-
norubicin, THP-doxorubicin, and aclacinomycin, was investi-
gated in vitro. Substantial differences were noted concerning
the enhancement by the combined treatment, raising the
question as to the relevant physical or chemical properties of
the substances on the one hand and the mechanism of this
interaction of shock waves and drugs on the other hand. It
was hypothesised that lipophilicity, as one determinant of
drug uptake, and cytotoxicity might be properties influencing
the interaction of shock waves and drugs.
Materials and methods
Cell line
L1210 mouse leukaemia cells (kindly provided by Dr. H.P.
Kraemer, Behringwerke, Marburg, Germany) were grown at
37°C as suspension culture in NunclonO-flasks (Nunc, Wies-
baden, Germany) in RPMI 1640 medium containing 15%
heat inactivated foetal calf serum, 2% sodium pyruvate, and
1% antibiotic-antimycotic solution (Gibco, Eggenstein, Ger-
many) in a humidified atmosphere containing 5% CO2.
Under these conditions, cells proliferated with a doubling time
of 11-12 h. In all experiments, log phase single cell suspen-
sions, harvested without trypsinisation, and with a viability
greater than 98% were used.
Shock waves and exposure vials
The principle of electrohydraulic shock wave generation has
been described earlier (Forssmann et al., 1977). Briefly, shock
waves were generated with a Dornier XL1 lithotripter (Dor-
nier Medizintechnik, Germering, Germany) by underwater
spark discharge between the two tips of an electrode located
in a metal hemi-ellipsoid which was used as focusing device.
The generator was operated at 80 nF capacitance, and a
voltage of 25 kV, unless otherwise indicated. The discharge
rate was 100 min-. For the experiments electrodes were not
used prior to the first 100 discharges. As one electrode was
used per vial, the electrode condition was similar in all
experiments. The water in the lithotripter tank, maintained at
35-37°C, was degassed by a vacuum pump; oxygen content,
as determined with an oximeter OXI 96 (WTW, Weilheim,
Germany, was 0.5-1 mg 1-1. According to pressure measure-
ments (Mueller, 1990) shock waves generated at operating
voltages of 20 kV and 26 kV have peak positive pressures of
82 MPa and 92 MPa respectively; the focal regions, defined
as the isobar representing 50% of peak positive pressure, are
22 mm-5 mm and 31 mm 5.8 mm respectively (length-width).
The cells were exposed in polypropylene vials with an inner
diameter of 11.7 mm and a height of 47 mm (Interchem,
Muenchen, Germany). The vials were positioned so that the
geometric focus of the ellipsoid, indicated by the point of
intersection of two-laser beams, was located 10 mm above
their bottom.
Drugs
Cisplatin and doxorubicin were chosen as these compounds
are widely used in cancer therapy. Daunorubicin, THP-
doxorubicin and aclacinomycin were chosen since these drugs
cover a wide range of lipophilicity (Hoffmann et al., 1990).
Cisplatin (Behringwerke, Marburg, Germany) was diluted in
culture medium before each experiment. Stock solutions of
doxorubicin and daunorubicin (Farmitalia, Freiburg, Ger-
many), THP-doxorubicin and aclacinomycin (kindly supplied
by Dr H.P. Kraemer, Behringwerke) with 500 ig drug ml-'
were prepared in sterile 0.9% NaCI solution and kept frozen
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at - 80C. The drugs were diluted in culture medium before
use.
Viability andproliferation assay
Viability was determined by trypan blue dye exclusion (Ten-
nant, 1964). Equal amounts of cell suspension and trypan
blue (2 mg ml-' in 0.9% NaCl solution; Fluka, Buchs,
Switzerland) were mixed. After 3 min at room temperature
the unstained cells were counted in a hemocytometer. Their
number in treated samples was calculated as fraction of
viable cells from the untreated control in the respective
experiment.
Proliferation of cells that were viable after exposure to
shock waves and/or drugs was tested with the 3-4,5 di-
methylthiazol-2,5 diphenyl tetrazolium bromide (MTT) assay
(Mosmann, 1983; Carmichael et al., 1987; Twentyman &
Luscombe, 1987). One hundred lal cell suspension, containing
9 x 102 viable cells, and 50 JLI culture medium were plated
into each well of 96-well round bottom microtitre plates
(Nunc, Wiesbaden, Germany) and incubated at 37°C in a
humidified atmosphere containing 5% CO2. At least 12 rep-
licate wells were used to determine each data point. After
72 h, providing time for at least six cell duplications of
untreated control cells, 50 JLl MTT solution (2.5 mgmlI in
0.9% NaCl solution; Sigma, Taufkirchen, Germany) was
added to each well. After a further incubation of 4 h the
supernatant fluid was removed, 100;l DMSO (E. Merck,
Darmstadt, Germany) was added to each well, and absor-
bance at 492 nm was measured within 5 min using a 400 AT
plate reader (SLT Labinstruments, Overath, Germany). Pro-
liferation of treated samples was calculated as fraction of the
proliferation of untreated control cells in the respective
experiment.
Partition coefficient
Partitioning of the drugs between aqueous and lipid phase
was determined by measuring the optical density (OD) of
drug solutions (cisplatin at 500 ,gml-l in 0.9% NaCI solu-
tion; doxorubicin, daunorubicin, THP-doxorubicin, and acla-
cinomycin at 101!M in 10mM Tris-HCl, pH 7.0) before and
after extraction with an equal volume of n-octanol (Zene-
bergh et al., 1982). Measurements were performed at 300 nm
for cisplatin, at 435 nm for aclacinomycin, and at 480 nm for
daunorubicin, doxorubicin, and THP-doxorubicin. The parti-
tion coefficient was calculated according to (ODbefore extraction
-ODafter extraction)/ODafter extraction-
Drug cytotoxicity
Cytotoxicity of each of the five drugs without shock waves
was determined by establishing dose-response curves for a
72 h continuous exposure. Proliferation was determined with
the MTT assay with the culture medium containing the
appropriate drug. At least three concentrations per drug were
tested and the experiment was repeated at least twice for each
drug. From the dose-response curves the drug concentrations
that inhibited proliferation of L1210 cells by 50% (IC50) were
calculated.
Experimentalprocedures
Simultaneous exposure to shock waves and different drug con-
centrations For the five drugs, dose-response curves were
obtained with incubation times of 50 and 7 min, with or
without simultaneous exposure to 500 shock waves. Drug
concentrations were chosen according to the detectability of
reduced proliferation with the MTT assay. At least three
concentrations were tested per drug. During the 50 min
incubation with the drugs the time of shock wave application
was chosen randomly. Previous experiments had revealed no
difference of the cytotoxic effect on cells between application
of shock waves at the beginning or at the end of a 50 min
incubation with cisplatin (Wilmer et al., 1989). Seven minutes
was the shortest incubation time that could be tested with
this experimental setup. Two or more samples of 5.2 ml cell
suspension, containing 2 x 106 viable L1210 cells and the
appropriate drug at various concentrations, and two samples
with no drug were transferred into the exposure vials. One of
these latter samples received no shock wave treatment and
served as control, the other was used to assess the effect of
exposure to shock waves alone. The vial(s) not being exposed
to shock waves were placed peripherally in the waterbath
outside of the shock wave field. The experiment was repeated
at least twice for each drug concentration.
In this and the following experiments, cells were washed
twice in a 4-fold volume of Hank's balanced salt solution
immediately after drug and/or shock wave exposure and
resuspended in 2 ml culture medium. The number of viable
cells was determined and proliferation was assessed.
Shock waves generated at different operating voltages A
dose-response curve was obtained with 500 shock waves
generated at 15, 20, or 25 kV, with or without simultaneous
incubation with cisplatin (16.7,M) for 50min. Each experi-
ment consisted of two or more samples of 5.2 ml cell suspen-
sion, containing 2 x 106 viable L1210 cells, and one sample
receiving neither drug nor shock wave treatment serving as
control. The experiment was repeated twice for each operat-
ing voltage.
Sequential exposure to shock waves and cisplatin Sequential
exposure was tested with cisplatin (25gM). In one series, 500
shock waves at 25 kV were applied before a 7 min incubation
time with cisplatin. The interval between the end of shock
wave exposure and cisplatin incubation was 3 min, the
shortest interval that could be tested with this setup. In
another series, 7 min incubation with cisplatin was done first.
Cells were washed twice in a 4-fold volume of cold Hank's
balanced salt solution and resuspended in fresh culture
medium. Due to this, the interval between the end of cis-
platin incubation and exposure to 500 consecutive shock
waves at 25 kV was 60 min. The experiments were repeated
twice for each exposure sequence.
Data analysis
Relative proliferation is given as mean values ± standard
deviation of at least three independent experiments. In the
experiments with simultaneous exposure to shock waves and
drugs, treatment with shock waves alone reduced the relative
proliferation of viable cells to 0.86 ± 0.10 (n = 49). For the
evaluation of the interaction of shock waves and drugs, the
proliferation of cells that were additionally exposed to shock
waves was normalised for the effect of shock waves alone.
Survival curves were fitted to the data by non-linear regres-
sion analysis. The ratio of the drug concentration needed to
reduce proliferation of L1210 cells by 50% without shock
wave exposure divided by the dose needed to reduce pro-
liferation by 50% with shock wave treatment was calculated;
the ratios for a proliferation reduced by 60%, 70%, 80% and
90% were calculated in an analogous manner. The dose-
enhancement ratio (DER) is given as the mean of these five
ratios. Dependency of relative proliferation of cells exposed
to cisplatin and shock waves upon the operating voltage and
correlation of DER with molecular weight, partition coeffic-
ient, and IC50 of the drugs were tested with least-squares
linear regression analysis.
Results
The dose-response curves for a 50 min incubation with cis-
platin, doxorubicin, daunorubicin, THP-doxorubicin, and
aclacinomycin with or without additional exposure to 500
shock waves generated at 25kV are shown in Figure 1.
Proliferation was only assessed for cells that had been trypan
blue negative after the respective treatment. The curve result-
ing from exposure to cisplatin alone showed a marked initialINTERACTION OF LITHOTRIPTER SHOCK WAVES AND CYTOTOXIC DRUGS 71
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Figure 1 Dose-response curves for L1210 cells incubated for 50 min with cisplatin, daunorubicin, doxorubicin, THP-doxorubicin,
or aclacinomycin. Cells were exposed to the drugs alone (O and dashed curves) or additionally treated with 500 shock waves at
25 kV (@ and solid curves). Proliferation after combined treatment was normalised for the effect ofexposure to shock waves alone.
The points and bars represent mean values and standard deviations in three to six independent experiments. For clarity some ofthe
points are slightly offset. Curves were fitted to the data by non-linear regression analysis.
shoulder which was completely absent in the curve resulting
from combined exposure to cisplatin and shock waves. The
effect of cisplatin was enhanced with a DER of 2.0 by the
additional exposure to shock waves. For the other four
drugs, the course of the curves for exposure to the drugs
alone and for combined exposure to drug and shock waves
was almost identical. DERs were calculated to be 1.0 for
doxorubicin and daunorubicin, 0.9 for THP-doxorubicin,
and 1.2 for aclacinomycin.
The dose-response curves for a 7 min incubation with cis-
platin, doxorubicin, daunorubicin, THP-doxorubicin, and
aclacinomycin are shown in Figure 2. The curve resulting
from exposure to cisplatin alone showed a marked shoulder
which was again absent in the curve resulting from combined
exposure to cisplatin and 500 shock waves at 25 kV. With the
7 min incubation time the effect of cisplatin was enhanced
with a DER of 6.7 by the additional exposure to shock
waves. For the other four drugs, the course of the curves was
less affected by shock wave treatment. DERs for a 7min
incubation were higher than for a 50 min incubation with 1.7
for doxorubicin, 1.1 for daunorubicin, 1.2 for THP-doxo-
rubicin, and 1.6 for aclacinomycin.
The effect of exposure to 500 shock waves generated at 15,
20, or 25 kV and simultaneous incubation with cisplatin
(16.7gM) for 50 min is shown in Table I. Treatment with
cisplatin alone reduced the proliferation to 0.70 ± 0.04. Addi-
tional exposure to shock waves reduced the relative prolifera-
tion further in a dose-dependent manner.
Table I Relative proliferation oftrypan blue negative cells incubated
with cisplatin (16.7tiM) for 50 min and simultaneous exposure to 500
shock waves at 15, 20 or 25 kV
Treatment Relativeproliferation'
Cisplatin 0.70± 0.04
Cisplatin + shock waves at 15 kV 0.47±0.06
Cisplatin + shock waves at 20 kV 0.26±0.08
Cisplatin + shock waves at 25 kV 0.17±0.04
aMean values±s.d.; n = 3. Proliferation after combined treatment
was normalised for the effect of exposure to shock waves alone.
Additional exposure to shock waves reduced relative proliferation in a
dose-dependent manner (P<0.05; regression analysis with relative
proliferation as dependent variable).
The effect of sequential exposure to cisplatin (25j.M) for
7 min and 500 shock waves at 25 kV before or after cisplatin
exposure is shown in Table II. No enhanced effect of the
combined treatment could be demonstrated when the cells
were exposed to cisplatin before or after shock wave treat-
ment.
Molecular weights, partition coefficients, IC50 values, and
DERs resulting from exposure to shock waves during a 50 or
7 min incubation time with the drugs are summarised in
Table III. For the highly hydrophilic cisplatin, no partition-
ing could be detected. With an IC_j of 0.974 gM it revealed
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Figure 2 Dose-response curves for L1210 cells incubated for 7 min with cisplatin, daunorubicin, doxorubicin, THP-doxorubicin,
or aclacinomycin. Cells were exposed to the drugs alone (O and dashed curves) or additionally treated with 500 shock waves at
25 kV (0 and solid curves). Proliferation after combined treatment was normalised for the effect of exposure to shock waves alone.
The points and bars represent mean values and standard deviations in three to six independent experiments. For clarity some of the
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Table II Relative proliferation oftrypan bluenegative cells incubated
with cisplatin (25tLM) for 7 min and sequential exposure to 500 shock
waves at 25 kV before or after the incubation period
Treatment Relative proliferationa
Cisplatin 0.85±0.11
Shock waves before cisplatin 1.00±0.12
Shock waves after cisplatin 0.96±0.09
aMean values±s.d.; n = 3. Proliferation after combined treatment
was normalized for the effect of exposure to shock waves alone.
Table III Molecular weight, partition coefficient, IC_O of the tested
drugs, and DERs for the combination of shock waves and cytotoxic
drugs for an incubation time of 50 min and 7 min
Molecular Partition IC50a DER
Drugs weight coefficient (JiM) 50' 7'
Cisplatin 300.1 n.d. 0.974±0.109 2.0 6.7
Doxorubicin 580.0 1.1 0.019±0.002 1.0 1.7
Daunorubicin 564.0 1.6 0.022±0.004 1.0 1.1
THP-doxorubicin 664.1 41.2 0.003±0.0002 0.9 1.2
Aclacinomycin 881.9 185.0 0.025±0.008 1.2 1.6
aMean values± s.e.m.; n.d. = not demonstrable.
study. THP-doxorubicin, with a medium partition coefficient
of 41.2, showed the highest cytotoxicity with an IC50 of
0.003 1M. DERs as a function of cytotoxicity are shown in
Figure 3. The enhanced effect of the combined treatment
decreased with increasing cytotoxicity of the drugs. The
DERs did not correlate with the molecular weights or the
partition coefficients of the drugs.
Discussion
It has previously been demonstrated that shock waves disrupt
tumour cells in vitro (Russo et al., 1986; Brummer et al.,
1989; Wilmer et al., 1989; Gambihler et al., 1990). Addi-
tionally, shock waves have been reported to enhance the
antiproliferative effect of vinblastin (Oosterhof et al., 1989)
and cisplatin (Wilmer et al., 1989; Lee et al., 1990). Further
examination of a combination of shock waves with anti-
cancer drugs appeared therefore promising.
Substantial differences were noted between the DERs for
the various drugs. Alone the combination of shock waves
with cisplatin showed a clear and pronounced effect on cell
proliferation. Shock waves combined with THP-doxorubicin
or daunorubicin, on the other hand, yielded no enhancement
of the effect. Platinum drugs passively diffuse into cells at a
very slow rate (Richon et al., 1987). The uptake of THP-
doxorubicin is a very rapid process, and its high cytotoxic
activity as compared to other anthracylines has been related
to the ease with which THP-doxorubicin accumulates in cells
(Tapiero et al., 1986). Only small DERs were found for the
combination of shock waves with doxorubicin and aclacino-
mycin. Differences in the rates of uptake between these sub-
stances have been reported (Zenebergh et al., 1982), but it
appears that the uptake rate, if it is relevant for the combina-
tion with shock waves, is important only at very slow rates
similar to those of cisplatin. This view is supported by the
finding that only for cisplatin the DER was clearly higher
with a 7 min incubation as compared to the 50 min incuba-
tion while it was similar for the other drugs.
Several mechanisms of the interaction of shock waves and
anticancer drugs have to be taken into account. Shock waves
could cause ultrastructural changes within the cell making it
more susceptible to cytotoxic drugs. L1210 cells exposed to
shock waves have been shown to exhibit intracellular altera-
tions (Russo et al., 1987; Brauner et al., 1989); however, the
subpopulation showing these alterations may be identical
with cells detected as geometrically intact but nonviable
(Brummer et al., 1989). Furthermore, exposure to shock
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Figure 3 Dose enhancement ratios as a function of cytotoxicity
of cisplatin (circles), aclacinomycin (triangles), doxorubicin
(inverse triangles), daunorubicin (squares), and THP-doxorubicin
(diamonds) with the open symbols and the dashed line for the
DERs at a 50 min incubation time and the filled symbols and the
solid line for the DERs at a 7 min incubation time. Curves show
the regression lines. (R = 0.97 and 0.92; regression analysis with
DER at 50 and 7 min incubation as dependent variable).
ponding to previous results (Briummer et al., 1989; Wilmer et
al., 1989; Gambihler et al., 1990). Finally, DERs from com-
bined exposure to shock waves and anticancer drugs were
markedly different for the various substances making an
unspecific effect on cells that are considered viable after
exposure to shock waves less likely.
Sequential exposure to shock waves and drug did not
enhance the cytotoxic effect of cisplatin, thus indicating a
short-lived shock wave effect. Such an effect might be
mediated by free radicals. Cavitation, which is the generation
and movement of bubbles in a fluid (Apfel, 1982; Crum,
1982), is produced by shock waves in the lithotripter water-
bath (Coleman et al., 1987). High local temperatures caused
by cavitation lead to the formation of free radicals (Makino
et al., 1982). Yet, findings about cavitation in intact cells are
conflicting, and experiments on supersaturation with gases
demonstrated that bubbles were not generated within cells
(Hemmingsen & Hemmingsen, 1979). Although the forma-
tion of free radicals during shock wave application has been
described, cell killing by shock waves did not correlate with
their formation (Morgan et al., 1988; Gambihler, submitted).
So far, there is no evidence for a major contribution of the
high local temperatures or free radicals to the effect of shock
waves on tumour cells.
Another possibility of shock wave action is a temporary
increase of the permeability of the cellular membrane similar
to electropermeabilisation (Melvik et al., 1986). As the cyto-
toxic effect of cisplatin was only enhanced when cells were
treated with shock waves during drug exposure the increased
permeability would be a short-lived effect. An increased
membrane permeability by shock waves could also explain,
why only the effect of cisplatin was clearly enhanced. Due to
its hydrophilic property and the slow intracellular accumula-
tion, it could profit most from an increase in cell membrane
permeability. THP-doxorubicin on the other hand, would
profit least from an increased membrane permeability.
Because of its lipophilic nature, it is rapidly taken up even
without shock waves, and exerts cytotoxic activity on L1210
cells similar to that of cisplatin already at a 300 times lower
concentration. Thus, a temporary increase in membrane per-
meability appears to be the most likely explanation for the
highly selective effect of shock waves in the enhancement of
drug effects. Such a mechanism also allows to explain the
dependency of the DERs upon the incubation time. A study
on the effect of ultrasound on the cytotoxicity of doxorubicin
already demonstrated an increased intracellular drug level
after combined treatment (Loverock et al., 1990).
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Our further studies are aimed at the direct determination
of intracellular drug concentration after exposure to shock
waves. It could be demonstrated that shock waves can cause
accumulation of propidium iodide, a fluorescent dye which is
normally excluded by an intact cell membrane, in cells that
are still able to metabolise fluorescein diacetate, indicating
viability. Additional cell sorting experiments revealed that
these cells were still able to proliferate (Gambihler, submit-
ted).
The number of drugs tested in this study has been limited,
and further experiments are necessary to determine whether
there is a general relation between hydrophilic properties of
the drugs, slow uptake and high IC50 on the one hand, and a
pronounced enhancement of the drug effect by shock waves
on the other hand. Even higher DERs than in this study
might be detected with anticancer drugs that by themselves
cannot pass the tumour cell membrane. Since shock waves
can be well focused even deep in the body, their combination
with such drugs would open up the possibility to implement
local action of the drug in vivo.
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